DYN SCHEDULE 13G/A: SEC filing
An institutional holder
Filed with the SEC on · accession 0001274173-26-000206
DYN filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Aug 13, 2026. An institutional holder filed an amended Schedule 13G for Dyne Therapeutics, Inc. (DYN), indicating a change in its passive ownership position. The stock moved -0.8% by the first close after the filing.
Summary of the filing
An institutional holder filed an amended Schedule 13G for Dyne Therapeutics, Inc. (DYN), indicating a change in its passive ownership position. The filing includes a power of attorney and the primary ownership document.
Key details
How DYN stock reacted
Close before
$26.17
Aug 12, 2026
First close after
-0.80%
$25.96
5 trading days
+2.33%
$26.78
Since filing
-30.95%
$18.07
✦ Ask GOAX AI about this filing — what it means for DYN, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for DYN?
Click hereFrequently asked questions
What did DYN file with the SEC on Aug 13, 2026?
DYN filed a SCHEDULE 13G/A (SEC filing). An institutional holder filed an amended Schedule 13G for Dyne Therapeutics, Inc. (DYN), indicating a change in its passive ownership position. The filing includes a power of attorney and the primary ownership document.
How do I read a SCHEDULE 13G/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
How did DYN stock react to this filing?
DYN closed at $26.17 before the filing and $25.96 on Aug 13, 2026 (-0.80%). Five trading days later: $26.78 (+2.33%).
Other DYN SEC filings
- 8-K · SEC filingNov 5, 2026
- 10-Q · SEC filingNov 5, 2026
- 8-K · Fda approvalSep 29, 2026
- SCHEDULE 13G/A · SEC filingAug 13, 2026
- 8-K · SEC filingJul 29, 2026
- 10-Q · SEC filingJul 29, 2026
- 8-K · Secondary offeringJul 22, 2026
- 424B5 · Secondary offeringJul 22, 2026
- 424B5 · Secondary offeringJul 21, 2026
- 8-K · Fda approvalJul 20, 2026
Get alerts when DYN files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days